Cognitive dysfunction and antiphospholipid antibodies in systemic lupus erythematosus (Q35625220)

9 August 2017

1 reference

title

Cognitive dysfunction and antiphospholipid antibodies in systemic lupus erythematosus (English)

1 reference

systemic lupus erythematosus

9 August 2017

1 reference

cognitive dysfunction

1 reference

based on heuristic

inferred from title

0 references

author name string

S D Denburg

series ordinal

1

1 reference

9 August 2017

J A Denburg

series ordinal

2

1 reference

9 August 2017

publication date

1 January 2003

1 reference

9 August 2017

1 reference

9 August 2017

volume

12

1 reference

9 August 2017

issue

12

1 reference

9 August 2017

page(s)

883-890

1 reference

Nervous system lupus: pathogenesis and rationale for therapy

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

Lupus and the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

The neuropsychiatric manifestations of systemic lupus erythematosus: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

Serial MRI and neurobehavioural findings after mild to moderate closed head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

SPECT, MR and quantitative MR imaging: correlates with neuropsychological and psychological outcome in traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

Quantitative electroencephalography. A new approach to the diagnosis of cerebral dysfunction in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

Magnetic resonance imaging of central nervous system lesions in patients with lupus erythematosus. Correlation with clinical remission and antineurofilament and anticardiolipin antibody titers

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

Positron emission tomography in neuropsychiatric lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

Neuropsychiatric systemic lupus erythematosus before and after immunosuppressive treatment: a FDG PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

Cerebral blood flow in systemic lupus erythematosus with and without central nervous system involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

Cerebral blood flow in systemic lupus erythematosus with or without cerebral complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

Oxygen-15 brain scanning for detection of cerebral involvement in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

Fluctuating cognitive abnormalities and cerebral glucose metabolism in neuropsychiatric systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

Magnetic resonance imaging of the brain and cerebral proton spectroscopy in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

Decreased regional cerebral metabolic rate for glucose in systemic lupus erythematosus patients with psychiatric symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

Neuroimaging in neuropsychiatric systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

Cerebral computed tomography and electroencephalography compared with neuropsychological findings in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

Proton magnetic resonance spectroscopy of systemic lupus erythematosus involving the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

Magnetic resonance imaging abnormalities and cognitive deficits in systemic lupus erythematosus patients without overt central nervous system disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

Psychiatric disorder and cognitive impairment in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

Lack of superiority of steroids plus plasma exchange to steroids alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome. A prospective, randomized trial in 78 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

Determinants of cognitive performance in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

Cognitive impairment in systemic lupus erythematosus: a follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

Positron emission tomography and magnetic resonance imaging for cerebral involvement in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

Assessment of neuropsychological dysfunction in the workplace: normative data from the Pittsburgh Occupational Exposures Test Battery

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

Neuropsychological deficit profiles in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

Antibodies to a specific surface antigen of T cells in human sera inhibiting mixed leukocyte culture reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

Brain-reactive lymphocytotoxic antibodies in the serum of patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

Serum lymphocytotoxic antibodies and neurocognitive function in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

Neuropsychological correlates of serum lymphocytotoxic antibodies in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

Behavioral effects of infection with IL-6 adenovector

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

Neurotoxic properties of cerebrospinal fluid from behaviorally impaired autoimmune mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

Antiphospholipid antibodies in systemic lupus erythematosus: clinical and laboratory associations in 111 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

Lupus anticoagulants, anticardiolipin antibodies, and cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

Pathology and pathogenesis of vascular injury in systemic lupus erythematosus. Interactions of inflammatory cells and activated endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

The role of FDG-PET, HMPAO-SPET and MRI in the detection of brain involvement in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

Discrepancy between regional cerebral blood flow and glucose metabolism of the brain in systemic lupus erythematosus patients with normal brain magnetic resonance imaging findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

Cerebral magnetic resonance imaging in patients with or without antiphospholipid antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

Alterations of cerebral blood flow and antiphospholipid antibodies in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

Anticardiolipin antibodies in normal subjects. Neuropsychological correlates and MRI findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

The association between sequential changes in serum antineuronal antibodies and neuropsychiatric systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

The association between the antiphospholipid antibody syndrome and neuropsychological impairment in SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

Neuropsychological deficits associated with antiphospholipid antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

A Controlled study of the prevalence of cognitive dysfunction in randomly selected patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU497OA

10.1191/0961203303LU497OA

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference